HP1, central to heterochromatin formation and gene silencing, has its functionality intricately tied to the chromatin landscape. Activating HP1's function generally involves enhancing its ability to bind to its target sites in heterochromatin or increasing its operational prevalence in specific chromosomal regions. One pivotal route for HP1 activation is through the use of DNA methyltransferase, such as 5-Azacytidine and Zebularine. These chemicals activate chromatin remodeling by altering DNA methylation patterns, which in turn, bolsters HP1's binding to heterochromatin regions, amplifying its operational footprint.
Another significant class of HP1 activators includes histone deacetylase Compounds like Trichostatin A, Sodium butyrate, Mocetinostat, and Entinostat elevate histone acetylation levels. This elevation translates to the activation of specific chromatin regions, making them more hospitable to HP1 binding. As a consequence, HP1's functional role in these domains is enhanced. Furthermore, the modulation of histone methylation, achieved through agents such as Chaetocin and BIX-01294, plays a crucial role in activating certain chromatin sites. This activation improves HP1's binding efficiency and amplifies its functional contribution in gene silencing and heterochromatin formation. In essence, the chemical activators of HP1 work in tandem with the intricate chromatin architecture, promoting conditions that maximize HP1's operational efficacy.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor. Reducing DNA methylation with 5-Azacytidine can activate chromatin remodeling. This enhances HP1's binding to heterochromatin regions, effectively increasing its functional presence. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor. Increasing histone acetylation levels can activate regions of the chromatin, making them more accessible. This alteration aids HP1 in binding more effectively to its target sites, thus amplifying its function. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor. By elevating histone acetylation, Sodium butyrate can activate chromatin regions, facilitating HP1's binding and enhancing its functional role in those domains. | ||||||
5′-Deoxy-5′-methylthioadenosine | 2457-80-9 | sc-202427 | 50 mg | $122.00 | 1 | |
A molecule involved in methylation reactions, which can activate specific histone methylation patterns. These activated methylation marks can enhance HP1's binding affinity and its subsequent functions. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
DNA methyltransferase inhibitor. By altering DNA methylation patterns, Zebularine activates chromatin regions, enhancing HP1’s anchoring and functional role in those domains. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
By inhibiting the histone methyltransferase G9a, it alters histone methylation patterns. This can activate specific chromatin sites, enhancing HP1's binding and function. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
By inhibiting the histone methyltransferase EZH2, EPZ-6438 can activate certain chromatin configurations. This activation enhances the sites where HP1 can effectively bind and function. | ||||||